As of 2024-12-12, the Relative Valuation of Kuros Biosciences AG (KURN.SW) is (1.45) CHF. This relative valuation is based on P/E multiples. With the latest stock price at 21.60 CHF, the upside of Kuros Biosciences AG based on Relative Valuation is -106.7%.
The range of the Relative Valuation is (1.16) - (1.74) CHF.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.9x - 7.4x | 6.2x |
| Forward P/E multiples | 4.9x - 7.4x | 6.2x |
| Fair Price | (1.16) - (1.74) | (1.45) |
| Upside | -105.4% - -108.0% | -106.7% |
| Date | P/E |
| 2024-12-04 | -83.06 |
| 2024-12-03 | -84.93 |
| 2024-12-02 | -88.54 |
| 2024-11-29 | -94.27 |
| 2024-11-28 | -93.42 |
| 2024-11-27 | -96.18 |
| 2024-11-26 | -98.52 |
| 2024-11-25 | -99.79 |
| 2024-11-22 | -103.19 |
| 2024-11-21 | -95.12 |
| 2024-11-20 | -103.40 |
| 2024-11-19 | -96.18 |
| 2024-11-18 | -85.14 |
| 2024-11-15 | -105.95 |
| 2024-11-14 | -132.70 |
| 2024-11-13 | -124.00 |
| 2024-11-12 | -119.96 |
| 2024-11-11 | -122.09 |
| 2024-11-08 | -118.05 |
| 2024-11-07 | -120.60 |
| 2024-11-06 | -116.78 |
| 2024-11-05 | -118.48 |
| 2024-11-04 | -115.93 |
| 2024-11-01 | -114.66 |
| 2024-10-31 | -105.95 |
| 2024-10-30 | -108.71 |
| 2024-10-29 | -109.35 |
| 2024-10-28 | -104.89 |
| 2024-10-25 | -102.98 |
| 2024-10-24 | -104.89 |
| 2024-10-23 | -109.14 |
| 2024-10-22 | -103.62 |
| 2024-10-21 | -101.92 |
| 2024-10-18 | -100.64 |
| 2024-10-17 | -102.77 |
| 2024-10-16 | -98.94 |
| 2024-10-15 | -97.67 |
| 2024-10-14 | -95.55 |
| 2024-10-11 | -84.17 |
| 2024-10-10 | -76.95 |
| 2024-10-09 | -81.53 |
| 2024-10-08 | -81.11 |
| 2024-10-07 | -82.04 |
| 2024-10-04 | -78.99 |
| 2024-10-03 | -74.40 |
| 2024-10-02 | -74.48 |
| 2024-10-01 | -75.84 |
| 2024-09-30 | -77.80 |
| 2024-09-27 | -78.65 |
| 2024-09-26 | -78.65 |